ClinicalTrials.Veeva

Menu

Inguinal Hernia Study Using Biodesign IHM

Cook Group logo

Cook Group

Status

Completed

Conditions

Inguinal Hernia

Treatments

Device: Biodesign IHM
Device: Polypropylene mesh

Study type

Interventional

Funder types

Industry

Identifiers

NCT00393887
H-28044
05-003

Details and patient eligibility

About

Aim is to evaluate outcomes of inguinal hernia repair incorporating the standard Lichtenstein (open) repair using Biodesign IHM in a double blind (physician evaluator and patient will be blinded), randomized, prospective comparative study with polypropylene mesh. Primary outcome is recurrence at 1 year. Hernia recurrence will be confirmed via ultrasound or CT scan.

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age
  • Diagnosis of Unilateral inguinal hernia repair
  • Able to provide written consent

Exclusion criteria

  • Incarcerated hernia
  • Allergic or religious beliefs that disallow porcine material
  • Previous hernia repair on the designated hernia site
  • Class IV or V anesthesia requirements
  • Bowel obstruction
  • Peritonitis
  • Life expectancy < 3 years

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

100 participants in 2 patient groups

1
Experimental group
Description:
Biodesign IHM Graft placement
Treatment:
Device: Biodesign IHM
2
Active Comparator group
Description:
Polypropylene mesh placement
Treatment:
Device: Polypropylene mesh

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems